Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases

Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases Ann Hematol (2017) 96:1769–1770 DOI 10.1007/s00277-017-3079-6 LETTER TO THE EDITOR Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases 1 2 3 4 2,5 Jessica C. Griffin & Nayef Aqel & Wenchee Siow & Marquita Camilleri & Robert Ayto Received: 10 June 2017 /Accepted: 23 July 2017 /Published online: 1 August 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, and negative for CD34, CD117, MPO and CD33, compatible Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a with BPDCN (Fig. 1, d2). Infiltrative cells on lymph node rare aggressive disease characterised by clonal proliferation of biopsy were positive for CD4, CD56 and CD123. plasmacytoid dendritic cell precursors [1]. Defined as a mye- The patient commenced FLAG-IDA chemotherapy achiev- ing haematological and radiological complete remission post loid malignancy by the World Health Organisation [2], it has distinct morphological and immunophenotypic features. We cycle 1. He relapsed rapidly post a second cycle of FLAG- present two cases of BPDCN, with a visual illustration of the IDA in the short assessment period prior to reduced intensity pathological characteristics. allogenic bone marrow transplant. He failed salvage with A 69-year-old male presented with 2 months history of high-dose methotrexate and died from sepsis http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Hematology Springer Journals

Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases

Loading next page...
 
/lp/springer_journal/blastic-plasmacytoid-dendritic-cell-neoplasm-a-pathological-tSgpDdB2sb

References (6)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Hematology; Oncology
ISSN
0939-5555
eISSN
1432-0584
DOI
10.1007/s00277-017-3079-6
pmid
28762083
Publisher site
See Article on Publisher Site

Abstract

Ann Hematol (2017) 96:1769–1770 DOI 10.1007/s00277-017-3079-6 LETTER TO THE EDITOR Blastic plasmacytoid dendritic cell neoplasm: a pathological illustration of two clinical cases 1 2 3 4 2,5 Jessica C. Griffin & Nayef Aqel & Wenchee Siow & Marquita Camilleri & Robert Ayto Received: 10 June 2017 /Accepted: 23 July 2017 /Published online: 1 August 2017 Springer-Verlag GmbH Germany 2017 Dear Editor, and negative for CD34, CD117, MPO and CD33, compatible Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a with BPDCN (Fig. 1, d2). Infiltrative cells on lymph node rare aggressive disease characterised by clonal proliferation of biopsy were positive for CD4, CD56 and CD123. plasmacytoid dendritic cell precursors [1]. Defined as a mye- The patient commenced FLAG-IDA chemotherapy achiev- ing haematological and radiological complete remission post loid malignancy by the World Health Organisation [2], it has distinct morphological and immunophenotypic features. We cycle 1. He relapsed rapidly post a second cycle of FLAG- present two cases of BPDCN, with a visual illustration of the IDA in the short assessment period prior to reduced intensity pathological characteristics. allogenic bone marrow transplant. He failed salvage with A 69-year-old male presented with 2 months history of high-dose methotrexate and died from sepsis

Journal

Annals of HematologySpringer Journals

Published: Aug 1, 2017

There are no references for this article.